Outcomes: Wedge resection versus lobectomy for non-small cell lung cancer at the Cancer Centre of Southeastern Ontario 1998-2009

Canadian Journal of Surgery

Volumn 56, Issue 6, 2013, Pages

  McGuire, Anna L ^a   Hopman, Wilma M ^b   Petsikas, Dimitri ^c   Reid, Ken ^c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b KINGSTON GENERAL HOSPITAL   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANADA; CANCER CENTER; CARCINOMA, NON-SMALL-CELL LUNG; COMPARATIVE STUDY; FEMALE; HUMAN; LUNG NEOPLASMS; LUNG RESECTION; MALE; MIDDLE AGED; PROCEDURES; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME; ARTICLE; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METHODOLOGY;

CANCER CARE FACILITIES; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; ONTARIO; PNEUMONECTOMY; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84893154166     PISSN: 0008428X     EISSN: 14882310     Source Type: Journal    
DOI: 10.1503/cjs.006311     Document Type: Article

References (46)

1. National Comprehensive Cancer Network (NCCN) Practice Guidelines in Oncology. Non-small cell lung cancer, 2010.
2. Forquer JA, Fakiris AJ, McGarry RC, et al. Treatment options for stage I non-small-cell lung carcinoma patients not suitable for lobectomy. Expert Rev Anticancer Ther 2009;9:1443-53.
3. Shennib H, Bogart J, Herndon JE II, et al. Video-assisted wedge resection and local radiotherapy for peripheral lung cancer in high-risk patients: the cancer and leukemia group b (CALGB) 9335, a phase II, multi-institutional cooperative group study. J Thorac Cardiovasc Surg 2005;129:813-8.
4. Kaneda M, Watanabe F, Tarukawa T, et al. Limited operation for lung cancer in combination with postoperative radiation therapy. Ann Thorac Cardiovasc Surg 2007;13:15-20.
5. Voynov G, Heron DE, Lin CJ, et al. Intraoperative 125I Vicryl mesh brachytherapy after sublobar resection for high-risk stage I non-small cell lung cancer. Brachytherapy 2005;4:278-85.
6. Birdas TJ, Koehler RP, Colonias A, et al. Sublobar resection with brachytherapy versus lobectomy for stage Ib non-small cell lung cancer. Ann Thorac Surg 2006;81:434-439.
7. Fukuse T, Ogawa E, Chen F, et al. Limited surgery and radiofrequency ablation for recurrent lung cancer. Ann Thorac Surg 2006;82:1506-8.
8. Timmerman R, Paulus R, Galvin J, et al. RTOG 0236: Stereotactic body radiation therapy (SBRT) to treat medically inoperable early stage lung cancer patients. Proceedings of the American Society for Therapeutic Radiology and Oncology (ASTRO) Annual Meeting; Chicago, IL. Int J Radiat Oncol Biol Phys 2009;75(suppl):S3.
9. Sienel W, Dango S, Kirschbaum A, et al. Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer related survival than wedge resections. Eur J Cardiothorac Surg 2008;33:728-34.
10. El-Sherif A, Fernando HC, Santos R, et al. Margin and local recurrence after sublobar resection for non-small cell lung cancer. Ann Surg Oncol 2007;14:2400-5.
11. Sienel W, Stremmel C, Kirschbaum A, et al. Frequency of local recurrence following segmentectomy of stage IA non-small cell lung cancer is influenced by segment localization and width of resection margins-implications for patient selection for segmentectomy. Eur J Cardiothorac Surg 2007;31:522-7.
12. El-Sherif A, Gooding WE, Santos R, et al. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13 year analysis. Ann Thorac Surg 2006;82:408-15.
13. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Ann Thorac Surg 1995;60:615-22.
14. Jensik RJ, Faber LP, Kittle CF. Segmental resection for bronchogenic carcinoma. Ann Thorac Surg 1979;28:475-83.
15. Weissberg D, Straehley CJ, Scully NM, et al. Less than lobar resections for bronchogenic carcinoma. Scand J Thorac Cardiovasc Surg 1993;27:121-6.
16. Pastorino U, Valente M, Bedini V, et al. Limited resection for stage I lung cancer. Eur J Surg Oncol 1991; 17:42-6.
17. Lederle FA. Lobectomy versus limited resection in T1N0 lung cancer. Ann Thorac Surg 1996;62:1249-50.
18. Rubinstein LV, Ginsberg RJ. Lobectomy versus limited resection in T1N0 lung cancer. Ann Thorac Surg 1995;60:615-22.
19. Nakamura H, Kawasaki N, Taguchi M, et al. Survival following lobectomy versus limited resection for stage I lung cancer: a metaanalysis. Br J Cancer 2005;92:1033-7.
20. Nakamura H, Kazuyuki S, Kawasaki N, et al. History of limited resection for non-small cell lung cancer. Ann Thorac Cardiovasc Surg 2005;11:356-62.
21. Fields RC, Meyers BF. Sublobar resections for lung cancer. Semin Thorac Cardiovasc Surg 2006;18:85-91.
22. Pettiford BL, Schuchert MJ, Santos R, et al. Role of sublobar resection (segmentectomy and wedge resection) in the surgical management of non-small cell lung cancer. Thorac Surg Clin 2007;17:175-90.
23. Warren WH, Faber LP. Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma. Five-year survival and patterns of intrathoracic recurrance. J Thorac Cardiovasc Surg 1994;107:1087-94.
24. Kodama K, Doi O, Higashiyama M, et al. Intentional limited resection for selected patients with T1N0M0 non-small cell lung cancer: a single institution study. J Thorac Cardiovasc Surg 1997;114:347-53.
25. Koike T, Yamato Y, Yoshiya K, et al. Intentional limited pulmonary resection for peripheral T1N0M0 small-sized lung cancer. J Thorac Cardiovasc Surg 2003;125:924-8.
26. Campione A, Ligabue T, Luzzi L, et al. Comparison between segmentectomy and larger resection of stage IA non-small cell lung carcinoma. J Cardiovasc Surg (Torino) 2004;45:67-70.
27. Martin-Ucar AE, Makas A, Pilling JE, et al. A case-matched study of anatomical segmentectomy versus lobectomy for stage I lung cancer in high-risk patients. Eur J Cardiothorac Surg 2005;27:675-9.
28. Mery CM, Pappas AN, Bueno R, et al. Similar ling-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the Surveillance, Epidemiology, and End Results database. Chest 2005;128:237-45.
29. Okada M, Nishio W, Sakamoto T, et al. Effect of tumour size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection. J Thorac Cardiovasc Surg 2005;129:87-93.
30. Griffin JP, Eastridge CE, Tolley EA, et al. Wedge resection for nonsmall cell lung cancer inpatients with pulmonary insufficiency: prospective ten year survival. J Thorac Oncol 2006;1:960-4.
31. Kraev A, Rassias D, Vetto J, et al. Wedge resection versus lobectomy: 10-year survival in stage I primary lung cancer. Chest 2007;131:136-40
32. Schuchert MJ, Pettiford BL, Keeley S, et al. Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer. Ann Thorac Surg 2007;84:926-33.
33. Sakurai H, Dobashi Y, Mizutani E, et al. Bronchoalveolar carcinoma of the lung 3 centimeters or less in diameter: a prognosis assessment. Ann Thorac Surg 2004;78:1728-33.
34. Rusch VW, Tsuchiya R, Tsuboi M, et al. Surgery of bronchoalveolar carcinoma and "very early" adenocarcinoma: An evolving standard of care? J Thorac Oncol 2006;1(9 Suppl):S27-31.
35. Asamura H, Suzuki K, Watanabe SI, et al. Clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions. Ann Thorac Surg 2003;76:1016-22.
36. Nakata M, Sawada S, Saeki H, et al. Prospective study of thoracoscopic limited resection for ground glass opacity selected by computed tomography. Ann Thorac Surg 2003;75:1601-6.
37. Nakamura H, Saji H, Ogata A, et al. Lung cancer patients showing pure ground glass opacity on computed tomography are good candidates for wedge resection. Lung Cancer 2004;44:61-8.
38. Yamada S, Kohno T. Video-assisted thoracic surgery for pure ground glass opacities 2 cm or less in diameter. Ann Thorac Surg 2004;77: 1911-5.
39. Yoshida J, Nagai K, Yokose T, et al. Limited resection trial for pulmonary ground-glass opacity: fifty-case experience. J Thorac Cardiovasc Surg 2005;129:991-6.
40. Ohtsuka T, Watanabe K, Kaji M, et al. A clinicopathological study of resected pulmonary nodules with focal pure ground-glass opacity. Eur J Cardiothorac Surg 2006;30:160-3.
41. AJCC Cancer Staging Manual, 6th ed, Greene FL, Page DL, Fleming ID, et al. (Eds). New York (NY): Springer-Verlag;2002. p. 435.
42. Rusch VW, Asamura H, Watanabe H, et al. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2009; 4:568.
43. Rami-Porta R, Ball D, Crowley J, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007;2:593.
44. Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007;2:706.
45. Groome PA, Bolejack V, Crowley JJ, et al. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007;2:694.
46. Postmus PE, Brambilla E, Chansky K. The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer. J Thorac Oncol 2007;2:686.